With selected research partners, we explore the future of risk coverage, assess changes in the risk landscape and act as a catalyst for industry change.
Uneven recovery paths as vaccine roll-out gains momentum.
The vaccination race is on and the first countries to reach herd immunity will have a significant economic and social advantage. As of now, the US and UK are much better positioned to reach herd immunity than the Euro area countries. China has already exceeded its pre-COVID-19 GDP level, while we expect the US and the Euro area to return to their pre-crisis output levels by Q4 2021and Q3 2022, respectively.
Economic Outlook
Economic and financial risk insights - Vaccine roll-out and stimulus herald cyclical recovery
Contact
sigma research
Our data driven research publications, including the industry leading sigma, enable risk focussed decision making and identify strategic opportunities in the re/insurance industry.